Table 2.
The effect of PM2.5 exposure on endocrine systems of the male and female individuals.
Serial No. | Exposure type | Study participants | Toxic effects | Reference |
---|---|---|---|---|
1. | PM2.5 at 3.7 μg/m3 | Prenatal exposure | increased neonatal TSH levels | (77) |
2. | Ambient PM2.5 at 8.13 µg/m3 concentration | Salivary cortisol output during pregnancy in a | decline in cortisol throughout the day with increasing exposure | (78) |
3. | NO2 at 24.4 ± 14.0 ppb and PM2.5 at 55.6 ± 41.5 μg/m3/day for 1-14 days |
COPD patients to the neuroendocrine response in COPD patients. | Increase in CRH, ACTH, and norepinephrine, and decreases in cortisol and epinephrine | (79) |
4. | PM2.5 | Prenatal exposure during third trimester of pregnancy | Increased depression risk and induces activation of the HPA axis | (80) |
5. | PM2.5 | Young adolescent girls | heightened HPA-axis stress responsivity, Increased biological sensitivity to social stress | (60) |
6. | PM2.5 | Exposure during pregnancy | Dose dependent increase in cortisol levels in cord blood, as the distance of exposure increased, the decrease in cord-blood cortisol level | (81) |
7. | 10 ppb of NO2, PM2.5 | 45-85 years old participants | 9.7% higher wake-up cortisol associated with a 10 ppb NO2, the cortisol curve became flatter over 5 years. | (82) |
8. | PM2.5 at 41.1 μg/m3 | Young adults | NO3 ion was still significantly associated with CRH, Increased CRH, ACTH and cortisol. | (83) |
9. | PM2.5 | Pregnant individuals | first-trimester exposures were associated with mild thyroid dysfunction throughout pregnancy, dose dependent increase in toxicity | (84) |
10. | PM2.5 | Elderly women with mean age of 73.5 ± 3.0 years | Higher risk of dementia in women with three estrogen receptors with SNPs | (85) |
11. | PM2.5, O3 and NO2 | Air pollutants and hormone-assessed pubertal development | No statistical effect on hormone levels of E2 and testosterone | (86) |
12. | Three-years exposure to PM2.5 | Dementia-free women aged 80 and older | episodic memory declines mediated by depressive symptoms | (87) |
13. | PM2.5 | Black women | not associated with a higher risk of breast cancer except for some geographic areas | (88) |
14. | PM2.5 | Pre-conception and early prenatal periods | can lead to altered steroid adaptation during the state of pregnancy | (89) |
15. | PM2.5, NO2 | Women with 1-year familial breast cancer risk | Increased risk among women with a higher familial risk with NO2 only | (52) |
16. | Improved air quality with PM2.5 | Exposure for 3 years in older women of less or more than 80 years with no dementia | improvement in long-term AQ in late life was associated with slower cognitive declines in older women | (90) |
17. | NO2, CO, SO2, or PM2.5, PM10 | Female adults aged ≥ 40 years | Increased risk of osteoporosis in female with PM10 only | (91) |
18. | PM2.5 | All cause ovarian cancer patients 18–79 years | PM2.5 concentrations were associated with an increased risk of all-cause mortality. | (92) |
19. | PM2.5 4.9 to 17.5 µg/m3 | 31 years old female participants | Weak inverse associations with POM, no dose response relationships | (93) |
20. | PM2.5 and PM10 through road exposure | 150 mother-newborn pairs | Directly related to increased cortisol levels in cord-blood | (81) |
21. | NO2 at 10 ppb and PM2.5 | 45–85 years old participants | Higher wake-up salivary cortisol with NO2 only which flattened over 5 years | (82) |
22. | PM2.5 in residential areas | Women in third trimester of pregnancy | More severe depressive symptoms and activation of HPA axis | (80) |
23. | NO2, O3 and PM2.5 | Obese Latino children and adolescents | Higher O3 exposure caused higher morning cortisol PM2.5 exposure (4–10 months) caused lower serum morning cortisol. |
(94) |
24. | PM2.5 at 41.1 μg/m3 | CRH, ACTH and cortisol in young adults | Water-soluble inorganic constituents especially, NO3, caused stronger activation of HPA axis | (83) |
25. | PM2.5, PM10 | Participants from couples who underwent in-vitro fertilization treatment | PM2.5 increased seminal testosterone and malondialdehyde, and reduced sperm progressive motility. | (95) |
26. | PM2.5 | Prenatal exposure to pregnant individuals | Reduced anogenital distance of new born | (96) |
27. | PM2.5 | Pregnant individuals in third trimester | Increased in cord blood levels of 17α-hydroxy-pregnenolone | (97) |
28. | PM2.5, SO2 and CO | women undergoing assisted reproductive procedure | Reduced testosterone, progesterone and FSH | (98) |
29. | PM2.5, NO2, SO2, CO, and O3 | Effect on testosterone, FSH, LH, E2, PRL in men aged 20–55 years | immediate and short-term cumulative PM2.5 reduced testosterone. | (99) |
30. | PM2.5, NO2 and PM10 | infertile men | PM2.5, and NO2 were negatively associated with sperm morphology. | (100) |
31. | PM1, PM2.5, and PM10 | Rural adult male and female | PM2.5 increased the testosterone in male and reduced progesterone in both male and female. | (101) |
32. | PM2.5 particles and bound eight PAHs | Male college students | LMW-PAHs negatively affected sperm morphology, PAHs increased sperm motility. | (102) |
33. | single-day and cumulative effects of air pollutants of PM2.5, SO2, and NO2 | Male young adults | PM2.5 concentrations were positively associated with E2. SO2 and O3 reduced E2. | (103) |
34. | PM2.5, CO, NO2, PM10 | Infertile men | PM2.5, CO and NO2 were negatively associated with the level of testosterone, PM2.5 also caused immature chromatin |
(104) |
35. | PM2.5 | fertile men of 20-45 years | Decreased sperm motility, total motility, and sperm quality | (105) |
36. | PM2.5, PM10, SO2, NO2, CO, and O3
14-18 µg/m3 During the third trimester |
Women with preterm birth information or low-birth weight | Low birth weight risk was associated with PM2.5, NO2, and O3 | (42) |
ACTH, adrenocorticotropic hormone; CRH, Increased corticotropin releasing hormone; COPD, Chronic obstructive pulmonary disease; E2, Estradiol; FSH, follicle stimulating hormone; HPA, Hypothalamus pituitary axis; LH, luteinizing hormone; LMW, low molecular weight; PAH, Poly aromatic amines; POM, Polycystic ovarian morphology; PRL, prolactin; SNP, Single nucleotide polymorphism.